Suppr超能文献

计算机预测的 CB1 大麻素受体突变体显示出不同的盐桥模式,这些模式与它们在 G 蛋白偶联水平、热稳定性和配体结合方面反映的组成型活性水平相关。

Computationally-predicted CB1 cannabinoid receptor mutants show distinct patterns of salt-bridges that correlate with their level of constitutive activity reflected in G protein coupling levels, thermal stability, and ligand binding.

机构信息

Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut 06269-3092, USA.

出版信息

Proteins. 2013 Aug;81(8):1304-17. doi: 10.1002/prot.24264. Epub 2013 Jun 14.

Abstract

The cannabinoid receptor 1 (CB1), a member of the class A G-protein-coupled receptor (GPCR) family, possesses an observable level of constitutive activity. Its activation mechanism, however, has yet to be elucidated. Previously we discovered dramatic changes in CB1 activity due to single mutations; T3.46A, which made the receptor inactive, and T3.46I and L3.43A, which made it essentially fully constitutively active. Our subsequent prediction of the structures of these mutant receptors indicated that these changes in activity are explained in terms of the pattern of salt-bridges in the receptor region involving transmembrane domains 2, 3, 5, and 6. Here we identified key salt-bridges, R2.37 + D6.30 and D2.63 + K3.28, critical for CB1 inactive and active states, respectively, and generated new mutant receptors that we predicted would change CB1 activity by either precluding or promoting these interactions. We find that breaking the R2.37 + D6.30 salt-bridge resulted in substantial increase in G-protein coupling activity and reduced thermal stability relative to the wild-type reflecting the changes in constitutive activity from inactive to active. In contrast, breaking the D2.63 + K3.28 salt-bridge produced the opposite profile suggesting this interaction is critical for the receptor activation. Thus, we demonstrate an excellent correlation with the predicted pattern of key salt-bridges and experimental levels of activity and conformational flexibility. These results are also consistent with the extended ternary complex model with respect to shifts in agonist and inverse agonist affinity and provide a powerful framework for understanding the molecular basis for the multiple stages of CB1 activation and that of other GPCRs in general.

摘要

大麻素受体 1(CB1)是 A 类 G 蛋白偶联受体(GPCR)家族的成员,具有可观察到的固有活性。然而,其激活机制尚未阐明。以前,我们发现由于单一突变,CB1 活性会发生剧烈变化;T3.46A 使受体失活,而 T3.46I 和 L3.43A 使它基本完全固有激活。我们随后对这些突变受体的结构进行了预测,表明这些活性变化可以用涉及跨膜域 2、3、5 和 6 的受体区域中的盐桥模式来解释。在这里,我们确定了关键的盐桥,R2.37 + D6.30 和 D2.63 + K3.28,分别对 CB1 的非活性和活性状态至关重要,并生成了我们预测会改变 CB1 活性的新突变受体,要么排除要么促进这些相互作用。我们发现,打破 R2.37 + D6.30 盐桥会导致 G 蛋白偶联活性的大幅增加,并降低与野生型相比的热稳定性,反映了从非活性到活性的固有活性变化。相比之下,打破 D2.63 + K3.28 盐桥产生了相反的结果,表明这种相互作用对于受体的激活至关重要。因此,我们证明了与预测的关键盐桥模式和实验活性和构象灵活性水平之间的极好相关性。这些结果也与扩展的三元复合物模型一致,涉及激动剂和反向激动剂亲和力的变化,并为理解 CB1 激活的多个阶段以及其他 GPCR 一般的分子基础提供了一个强大的框架。

相似文献

5
Structural dynamics and energetics underlying allosteric inactivation of the cannabinoid receptor CB1.
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8469-74. doi: 10.1073/pnas.1500895112. Epub 2015 Jun 22.
6
The effects of charge-neutralizing mutation D6.30N on the functions of CB1 and CB2 cannabinoid receptors.
FEBS Lett. 2006 Oct 2;580(22):5392-8. doi: 10.1016/j.febslet.2006.09.001. Epub 2006 Sep 12.
10
Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα protein inhibitor.
Neuropharmacology. 2018 May 1;133:107-120. doi: 10.1016/j.neuropharm.2018.01.024.

引用本文的文献

1
Differential Behavior of Conformational Dynamics in Active and Inactive States of Cannabinoid Receptor 1.
J Phys Chem B. 2024 Sep 5;128(35):8437-8447. doi: 10.1021/acs.jpcb.4c02828. Epub 2024 Aug 22.
4
Predicted structure and cell signaling of TAS2R14 reveal receptor hyper-flexibility for detecting diverse bitter tastes.
iScience. 2023 Mar 16;26(4):106422. doi: 10.1016/j.isci.2023.106422. eCollection 2023 Apr 21.
5
Activation mechanism of the μ-opioid receptor by an allosteric modulator.
Proc Natl Acad Sci U S A. 2022 Apr 19;119(16):e2121918119. doi: 10.1073/pnas.2121918119. Epub 2022 Apr 11.
6
Development of enhanced conformational sampling methods to probe the activation landscape of GPCRs.
Adv Protein Chem Struct Biol. 2022;128:325-359. doi: 10.1016/bs.apcsb.2021.11.001. Epub 2021 Dec 20.
8
Structures and Agonist Binding Sites of Bitter Taste Receptor TAS2R5 Complexed with Gi Protein and Validated against Experiment.
J Phys Chem Lett. 2021 Sep 30;12(38):9293-9300. doi: 10.1021/acs.jpclett.1c02162. Epub 2021 Sep 20.
9
Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids.
Bioorg Med Chem. 2021 Jul 1;41:116215. doi: 10.1016/j.bmc.2021.116215. Epub 2021 May 12.
10
Probing thermostability of detergent-solubilized CB receptor by parallel G protein-activation and ligand-binding assays.
J Biol Chem. 2020 Jan 3;295(1):181-190. doi: 10.1074/jbc.RA119.010696. Epub 2019 Nov 27.

本文引用的文献

1
Flat-Bottom Strategy for Improved Accuracy in Protein Side-Chain Placements.
J Chem Theory Comput. 2008 Dec 9;4(12):2160-9. doi: 10.1021/ct800196k.
4
Ligand functional selectivity and quantitative pharmacology at G protein-coupled receptors.
Expert Opin Drug Discov. 2011 Aug;6(8):811-25. doi: 10.1517/17460441.2011.586691. Epub 2011 May 24.
5
Crystal structure of a lipid G protein-coupled receptor.
Science. 2012 Feb 17;335(6070):851-5. doi: 10.1126/science.1215904.
7
Bihelix: Towards de novo structure prediction of an ensemble of G-protein coupled receptor conformations.
Proteins. 2012 Feb;80(2):505-18. doi: 10.1002/prot.23216. Epub 2011 Dec 15.
8
Activation mechanism of the β2-adrenergic receptor.
Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18684-9. doi: 10.1073/pnas.1110499108. Epub 2011 Oct 26.
10
Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine.
Structure. 2011 Sep 7;19(9):1283-93. doi: 10.1016/j.str.2011.06.014.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验